Virax Biolabs Group Limited - (VRAX) share price
Virax Biolabs Group Limited - (NASDAQ:VRAX) last traded at $0.79, down 32.89% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.00B and a 52-week range of $0.63 to $21.75.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $0.79 |
| 1-day move | -32.89% |
| 52-week range | $0.63 - $21.75 |
| Market cap | $0.00B |
| From 52-week high | -96.40% |
| Volume vs average | 1.8x |
| Falling Shares risk score | 86/100 (CRITICAL) |
| Country | United States |
Frequently asked questions
Why is Virax Biolabs Group Limited - falling today?
Virax Biolabs Group Limited - (NASDAQ:VRAX) is down 32.89% at its latest quote and trades 96.4% below its 52-week high, on volume 1.8x its average, at a new 52-week low. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Virax Biolabs Group Limited - share price today?
Virax Biolabs Group Limited - (NASDAQ:VRAX) last traded at $0.79, a -32.89% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Virax Biolabs Group Limited -?
Virax Biolabs Group Limited -'s 52-week low is $0.63 and its 52-week high is $21.75; the shares trade 96.4% below the high.
What is the market cap of Virax Biolabs Group Limited -?
Virax Biolabs Group Limited - has a market capitalisation of about $0.00B at the latest price.
What are the risks of investing in Virax Biolabs Group Limited -?
Falling Shares Intelligence rates Virax Biolabs Group Limited - 86/100 (CRITICAL) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com